Musculoskeletal Diseases
Diseases of the muscles and their associated ligaments and other connective tissue and of the bones and cartilage viewed collectively.
Subtype terms (11)
More specific conditions that are subtypes of Musculoskeletal Diseases in the MeSH hierarchy.
- Bone Diseases
91 drugs (48 approved, 43 experimental)
- Cartilage Diseases
33 drugs (9 approved, 24 experimental)
- Fasciitis
2 drugs approved
- Foot Deformities
5 drugs (4 approved, 1 experimental)
- Foot Diseases
5 drugs approved
- Hand Deformities
- Jaw Diseases
- Joint Diseases
58 drugs (31 approved, 27 experimental)
- Muscular Diseases
29 drugs (20 approved, 9 experimental)
- Musculoskeletal Abnormalities
4 drugs (3 approved, 1 experimental)
- Rheumatic Diseases
59 drugs (41 approved, 18 experimental)
Drugs by status
Approved for this indication (2)
Phase 4 trials (27)
- simvastatin
- diclofenac
- propofol
- vitamin d3
- chondroitin
- ketamine
- betamethasone
- gabapentin
- goserelin
- adalimumab
- acetaminophen
- plasma rich in growth factors
- lidocaine
- donepezil
- epinephrine
- remimazolam
- levobupivacaine
- acetylsalicylic acid
- estradiol
- testosterone
- dexmedetomidine
- triamcinolone
- midazolam
- rebamipide
- sodium chloride
- levonorgestrel
- Eupatilin
Phase 3 trials (23)
- levofloxacin
- allopurinol
- aceneuramic acid
- acetylcysteine
- deflazacort
- ibuprofen
- duloxetine
- elamipretide
- etanercept
- sevoflurane
- bone marrow derived mesenchymal stem cells
- naproxen
- ropivacaine
- ataluren
- sialic acid
- desflurane
- zoledronic acid
- autologous mesenchymal stem cells
- abobotulinumtoxinA
- ren001
- tong-luo-qu-tong
- qi-zheng-xiao-tong
- asp0367
Phase 2 trials (24)
- calcium carbonate
- calcium citrate
- calcium glucarate
- ketorolac
- platelet-rich plasma
- n-acetylmannosamine
- pamidronate
- pravastatin
- carboplatin
- allogeneic hematopoietic stem cells
- leflunomide
- bupivacaine
- cholesterol
- clonidine
- hydromorphone
- vinorelbine
- human fecal microbiota
- letrozole
- ergocalciferol
- difelikefalin
- ly3462817
- levi-04
- aoc 1001
- aoc 1020
Phase 1 trials (11)
Organizations
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (20)
- Cristália Produtos Químicos Farmacêuticos Ltda.
- PTC Therapeutics
- Guangzhou Medical University
- Katholieke Universiteit Leuven
- Nanjing Medical University
- Ochsner Health System
- Ohio State University
- Shanghai University of Traditional Chinese Medicine
- Wuhan University
- East Carolina University
- Kangbuk Samsung Hospital
- Tonix Pharmaceuticals
- Shanghai University
- Southern Medical University
- Liaoning Hospital of Traditional Chinese Medicine
- Sun Yat-Sen University
- Suzhou Hospital of Traditional Chinese Medicine
- Hubei University of Chinese Medicine
- Luoyang Osteopathy hospital of Henan
- The Fourth Central Hospital of Tianjin
Organization Involved with Phase 2 Indications (5)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (11)